CROCE, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 280
EU - Europa 219
AS - Asia 140
AF - Africa 1
Totale 640
Nazione #
US - Stati Uniti d'America 276
IE - Irlanda 176
CN - Cina 135
IT - Italia 23
DE - Germania 12
CA - Canada 4
SE - Svezia 3
JP - Giappone 2
BE - Belgio 1
FI - Finlandia 1
FR - Francia 1
GB - Regno Unito 1
HK - Hong Kong 1
IR - Iran 1
PL - Polonia 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 640
Città #
Dublin 176
Chandler 130
Nanjing 41
Princeton 21
Lawrence 20
Beijing 19
Medford 18
Jiaxing 16
Wilmington 11
Changsha 10
Hebei 10
Nanchang 10
Shenyang 8
Tianjin 6
Hangzhou 5
Pavia 5
Jacksonville 4
Böblingen 3
Dearborn 3
Legnano 3
Ningbo 3
Norwalk 3
Toronto 3
Borås 2
Fairfield 2
Milan 2
Orange 2
Redwood City 2
Tokyo 2
Woodbridge 2
Wuhan 2
Ann Arbor 1
Arsago Seprio 1
Brussels 1
Como 1
Fuzhou 1
Gauteng 1
Guangzhou 1
Hanover 1
Helsinki 1
Markham 1
Reston 1
Riyadh 1
San Francisco 1
Seattle 1
Taizhou 1
Warsaw 1
Zhengzhou 1
Totale 561
Nome #
Extracellular vesicles derived from mesenchymal cells: perspective treatment for cutaneous wound healing in pediatrics 48
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells 44
Granulation tissue-derived mesenchymal stromal cells: a potential application for burn wound healing in pediatric patients 42
Freeze-dried pharmaceutical formulations containing mesenchymal exosomes for acellular MSC immunomodulant therapy 41
CPAM type 2-derived mesenchymal stem cells: Malignancy risk study in a 14-month-old boy 37
A case report on filamin A gene mutation and progressive pulmonary disease in an infant: A lung tissued derived mesenchymal stem cell study 36
In vitro cytotoxicity and potency of freeze-dried MSC-secretome (Lyosecretome). 35
Freeze-dried and GMP-compliant pharmaceuticals containing mesenchymal exosomes for acellular MSC immunomodulant therapy 34
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease 33
Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine: in vitro cytotoxicity and potency 32
Microenvironment in neuroblastoma: Isolation and characterization of tumor-derived mesenchymal stromal cells 32
Mesenchymal stromal cells on bioscaffold for liver bioengineering 32
Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy 30
A hepatic scaffold from decellularized liver tissue: Food for thought 28
Silk sericin: from textile waste material to dermatological and cosmetic applications 26
Silk sericin for textile wastewater to high value product for dermatological and cosmetic use. 25
Engineered Full Thickness Electrospun Scaffold for Esophageal Tissue Regeneration: From In Vitro to In Vivo Approach 25
Silk sericin and circular economy: from a textile waste material to a pharmaceutical compound. 24
Eco-sustainable silk sericin from by-product of textile industry can be employed for cosmetic, dermatology and drug delivery 23
CD73-Adenosinergic Axis Mediates the Protective Effect of Extracellular Vesicles Derived from Mesenchymal Stromal Cells on Ischemic Renal Damage in a Rat Model of Donation after Circulatory Death 18
Shape memory engineered scaffold (SMES) for potential repair of neural tube defects 17
Commentary: Insulin-Producing Organoids Engineered From Islet and Amniotic Epithelial Cells to Treat Diabetes 11
Totale 673
Categoria #
all - tutte 1668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1668


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20185 0000 00 00 0302
2018/201918 0040 00 50 0414
2019/2020148 466700 00 03 98123
2020/202122 0042 02 05 6300
2021/202290 0040 12 36 111656
2022/2023387 3440025 3130 420 203000
Totale 673